|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received August 7, 2007
Accepted on September 12, 2007
ORIGINAL ARTICLES |
,
Departments of *Medicine, and Departments, of *Medicine, and
Pathology, Rush University Medical Center, Chicago, Illinois
Pathology, Rush University Medical Center, Chicago, Illinois
1 To whom correspondence should be addressed. E-mail: skorbet{at}aol.com.
| Abstract |
|---|
Background and objectives: The value of a complete remission in severe lupus nephritis is well known but little is known about the impact of a partial remission in this patient population. The purpose of this study was to evaluate the long-term prognosis of achieving a complete or partial remission in a well-defined group of patients with severe lupus nephritis.
Design, setting, participants, & measurements: In this study, 86 patients with diffuse lupus glomerulonephritis were reviewed for assessment of the value of a partial remission (50% reduction in baseline proteinuria to
1.5 g/d and
25% increase in baseline creatinine) and complete remission (proteinuria
0.33 g/d and serum creatinine
1.4 mg/dl) on outcomes compared with patients who did not attain a remission. These well-characterized patients were entered into a prospective therapeutic trial conducted by the Collaborative Study Group and were followed for more than 10 yr.
Results: All biopsies showed diffuse lupus nephritis. A complete remission was attained in 37 (43%) patients, a partial remission in 21 (24%) patients, and no remission in 28 (32%) patients. Baseline clinical and serologic features were similar among the groups, but patients with a complete remission had a lower serum creatinine and chronicity index compared with patients with partial or no remission. The patient survival at 10 yr was 95% for complete remission, 76% for partial remission, and 46% for no remission. The renal survival at 10 yr was 94% for complete remission, 45% for partial remission, and 19% for no remission, and the patient survival without end-stage renal disease at 10 yr was 92% for complete remission, 43% for partial remission, and 13% for no remission.
Conclusion: Even a partial remission in lupus nephritis is associated with a significantly better patient and renal survival compared with no remission.
This article has been cited by other articles:
![]() |
M. I. Danila, G. J. Pons-Estel, J. Zhang, L. M. Vila, J. D. Reveille, and G. S. Alarcon Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort Rheumatology, May 1, 2009; 48(5): 542 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Izmirly, L. Barisoni, J. P. Buyon, M. Y. Kim, T. L. Rivera, J. S. Schwartzman, J. M. Weisstuch, D. T. Liu, S. Bernstein, C.-E. Tseng, et al. Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis Rheumatology, May 1, 2009; 48(5): 513 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Glassock Multitarget Therapy of Lupus Nephritis: Base Hit or Home Run? J. Am. Soc. Nephrol., October 1, 2008; 19(10): 1842 - 1844. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |